Loading…
Based on limited metadata, this FDA Warning Letter issued to City Vapes Premium eJuice Inc. on February 28, 2020, concerns a tobacco product manufacturer, likely related to e-liquid or vaping products. Without access to the full letter text or subject line details, the specific regulatory violations cannot be identified, though they may relate to manufacturing practices, labeling, marketing claims, or product composition requirements under FDA tobacco regulations. The warning falls under FDA's tobacco product enforcement authority, though the specific issuing office is not indicated in the available metadata. A complete review of the full Warning Letter would be necessary to determine the exact nature and scope of the alleged violations.